SCHEMBL7129671

SCHEMBL7129671

CCOC(=O)CN1CC(=O)N(C)c2ccc([N+](=O)[O-])cc2C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.47
CASP3 P42574 1/20 0.47
CASP4 P49662 1/20 0.47
CASP7 P55210 1/20 0.47
CASP9 P55211 1/20 0.47
CASP6 P55212 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
LMNA P02545 2/20 0.43
PPARG P37231 1/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
GABRA1 P14867 3/20 0.41
GABRG2 P18507 3/20 0.41
GABRB3 P28472 3/20 0.41
GABRA5 P31644 3/20 0.41
GABRA3 P34903 3/20 0.41
ALDH1A1 P00352 6/20 0.41
GAA P10253 1/20 0.41
GABRA2 P47869 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324337 0.91 CASP1 (0.46) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7133634 0.88 MAPT (0.43) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7134290 0.83 TNF (0.50) RAB9ALMNAPPARGNR1H2NR1H3
SCHEMBL7133916 0.82 LMNA (0.43) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7133922 0.82 LMNA (0.43) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7133914 0.82 LMNA (0.43) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7393832 0.81 ALDH1A1 (0.43) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7137536 0.80 ALOX15 (0.48) LMNAGABRA1GABRG2GABRB3GABRA5
SCHEMBL7335912 0.79 MAPT (0.41) CASP1CASP3CASP4CASP7CASP9
SCHEMBL7539270 0.78 MAPT (0.41) CASP1CASP3CASP4CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506744-B1 Well as pharmaceutically usable salts and esters thereof, inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. Can be used in the form of HOFFMANN-LA ROCHE INC. 2003-01-14 US disclosed
WO-2001004103-A1 BENZAZEPINONES AND QUINAZOLINES F. HOFFMANN-LA ROCHE AG (CH) 2001-01-18 WO disclosed